Endocyte Reports Third Quarter 2012 Financial Results and Business Update

Endocyte Reports Third Quarter 2012 Financial Results and Business Update

[at noodls] – -MAA Filing Process for Vintafolide and Etarfolatide on Schedule for Completion by Year-End 2012 – -Conference call today at 4:30 EDT – WEST LAFAYETTE, Ind., Nov. 1, 2012 (GLOBE NEWSWIRE) — Endocyte, … more

View todays social media effects on ECYT

View the latest stocks trending across Twitter. Click to view dashboard

Share this post